ASLANLeather

🔺️A tourist identified as 40-year-old Tamirah Yasmeen Dix, a resident of Atlanta, Georgia, died Saturday night after suffering an apparent incident while at a zipline in Orocovis, PR 🇵🇷 ​According to preliminary information, the woman allegedly received a heavy blow to the face as she was preparing to go down the zipline. Based on the account provided by her relatives to agents of the Criminal Investigation Corps (CIC) of Vega Baja, Dix completed the course and later reunited with them. ​Following the activity, the group went to have lunch, but the tourist stated she did not wanted to eat. Shortly after, she went to the bathroom, where she vomited. Given the deterioration of her health, her relatives chose to return to the hotel where they were staying in Dorado. ​While traveling along Highway PR-693, the woman’s condition worsened, leading them to call the 9-1-1 Emergency System. An ambulance intercepted the vehicle and transported the tourist to the Orlando Health Doctor Center hospital in Dorado, where doctors attempted to resuscitate her. Nevertheless, she was pronounced dead at nightfall. ​The body will be transported to the Institute of Forensic Sciences in Río Piedras, where an autopsy will be performed to determine the exact cause of death. Rest in Power, beautiful.

Israel is the first state in history to legislate a death sentence that applies only to one ethnic group. There's a reason nobody has ever done this. It's a depth of evil beyond humanity itself.

Israel is the first state in history to legislate a death sentence that applies only to one ethnic group. There's a reason nobody has ever done this. It's a depth of evil beyond humanity itself.

Israel has now become the first state to codify a death sentence that applies in practice to one ethnic group, while another is effectively shielded from it.

A 21-year-old man from Long Island has made medical history as the first person in New York State to be cured of sickle cell disease. Sickle cell disease is a painful genetic disorder in which red blood cells become rigid, crescent-shaped, and prone to clumping. These deformed cells block blood vessels, triggering intense pain crises, organ damage, strokes, and a significantly reduced life expectancy. The condition affects approximately 100,000 people in the United States. The breakthrough treatment, called Lyfgenia (lovotibeglogene autotemcel), is a one-time gene therapy developed by bluebird bio. The process begins by collecting the patient’s own bone marrow stem cells. In the laboratory, scientists use a lentiviral vector to insert a functional gene that enables the production of healthy hemoglobin. After the patient undergoes chemotherapy to eliminate the faulty cells, the genetically modified stem cells are infused back into the body. Once engrafted, these corrected cells start producing normal, flexible red blood cells that flow smoothly through blood vessels without causing blockages. For Sebastien Beauzile, who had lived with severe sickle cell disease for over two decades, the results were transformative. Chronic pain that had defined much of his life vanished, and his blood parameters normalized. Doctors now consider him cured. While the therapy is complex, requires intensive preparation, and remains extremely expensive, it represents a major shift in how sickle cell disease is approached — moving from lifelong symptom management to a potential one-time curative solution. As more patients gain access, Lyfgenia and similar gene therapies could offer hope for a future where sickle cell is no longer a lifelong burden. This milestone at Cohen Children’s Medical Center marks an important step forward in genetic medicine and personalized cures.

Without drugs... what is the greatest weapon against anxiety and depression?

They’ve been fighting for many decades, Jane Fonda and Joan Baez.